Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Antibody treatments show promise for hair loss but need more research.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

CTE and FPHL are different hair loss types with unique causes.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.